drugset / Trial / NCT01714544

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

NCT01714544 ↗

Phase 4 Completed 60 enrolled Promius Pharma, LLC
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether Cloderm Cream is effective for topical treatment of moderate psoriasis over 28 days.

Timeline

Start
2012-10
Primary completion
2013-03
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Clocortolone Pivalate Small molecule 0.1 % Topical

Indications